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TITLE: Tracking tuberculosis incidence: time to tool up.  
 
Incidence of tuberculosis (TB) disease is a key metric for tracking TB burden and 
monitoring progress with control efforts. Incidence responsively measures success 
with primary prevention, is not muddied by different or changing disease duration, 
and is distinct from individual-level measures of programme success such as 
treatment outcomes. However, TB incidence cannot be directly measured. General 
population TB prevalence surveys are already challenging undertakings, and adding a 
longitudinal component is not feasible. 
 
In their article in this issue of IJTLD, Pandey and colleagues1 provide an example of a 
mathematical modelling approach to the problem of estimating TB incidence, 
applying their method to India -  the country with the largest number of TB cases in 
the world. They incorporate an understanding of the natural history of TB in a simple 
model and use data on TB prevalence and annual risk of infection (ARI) to estimate 
TB incidence. They also suggest evidence of more intense transmission in urban 
settings and poorer access to care in rural settings; features it would be interesting to 
investigate further. 
 
The familiar Styblo rules2 can be thought of as a simple mathematical model 
providing a quantitative mapping between TB incidence, TB prevalence and ARI. 
However, the use of mathematical modelling in TB burden estimation is much less 
developed than in the HIV world, where various approaches have been studied and 
are a core component of the UNAIDS burden estimation process.3 This is partly 
because TB presents additional challenges compared with HIV: survey data are rarer 
and less precise, routine data are prone to poorly quantified biases, and the underlying 
natural history and epidemiology are subject to greater uncertainty. These issues are 
not insurmountable, but do require a principled approach and careful treatment in 
modelling analyses. 
 
In common with the Styblo rules, Pandey and colleagues make use of data on ARI. 
ARI fell from favour as a tool for TB surveillance as limitations and difficulties of 
interpretation of the tuberculin skin test (TST) for latent TB infection (LTBI) 
emerged. However, as TB control improves and TB becomes rarer, TB prevalence 
surveys will become less feasible. Moreover, TB control programmes will need to 
place a greater emphasis on LTBI, providing another motivation for LTBI 
surveillance. Improved tests of LTBI that can identify recent infection, and those at 
greatest risk of developing TB, would be hugely useful tools for targeted preventive 
therapy, but a test of recent infection would also be an important tool for surveillance. 
There are hints that the new QuantiFERON-TB Gold Plus test may be better able to 
identify recent infection;4 but we are still largely looking to the future, whereas the 
development of HIV incidence assays and methodological work supporting their use 
in surveillance is much further progressed.5 
 
TB control is entering an exciting era. Achieving the End TB targets will require new 
tools; but effort to develop new methods of monitoring our progress will also be 
required. Diverse modelling approaches to synthesizing new and heterogeneous 
epidemiological data should be part of this effort.  
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